Learn More
Medchemexpress LLC Abiraterone acetate | 154229-18-2 | 99.91% | C26H33NO2 | 5 MG

Supplier: Medchemexpress LLC HY750545MG
Abiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. It is a proagent form of Abiraterone.
- Oral administration
- Potent, selective, and irreversible inhibitor of CYP17A1
- Exhibits antiandrogen activity
- Prodrug form of Abiraterone
- Inhibits 17,20-lyase and 17α-hydroxylase activity
- Inhibits proliferation of AR-positive prostate cancer cell lines
- Blocks synthesis of 5α-dione and DHT
- Inhibits CRPC progression
- Prolongs survival in castration-resistant prostate cancer (CRPC)
- Inhibits dehydroepiandrosterone (DHEA) depletion and Δ4-androstenedione (AD) accumulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.